Your browser doesn't support javascript.
loading
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis.
Abdel-Fatah, Tarek M A; Agarwal, Devika; Liu, Dong-Xu; Russell, Roslin; Rueda, Oscar M; Liu, Karen; Xu, Bing; Moseley, Paul M; Green, Andrew R; Pockley, Alan G; Rees, Robert C; Caldas, Carlos; Ellis, Ian O; Ball, Graham R; Chan, Stephen Y T.
Afiliação
  • Abdel-Fatah TMA; Clinical Oncology Department, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Agarwal D; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham, UK.
  • Liu DX; Liggins Institute, University of Auckland, Auckland, New Zealand; The Institute of Genetics and Cytology, Northeast Normal University, Changchun, China.
  • Russell R; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK.
  • Rueda OM; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK.
  • Liu K; Liggins Institute, University of Auckland, Auckland, New Zealand.
  • Xu B; Liggins Institute, University of Auckland, Auckland, New Zealand.
  • Moseley PM; Clinical Oncology Department, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Green AR; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Pockley AG; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham, UK.
  • Rees RC; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham, UK.
  • Caldas C; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK.
  • Ellis IO; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Ball GR; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Clifton Campus, Nottingham, UK.
  • Chan SYT; Clinical Oncology Department, Nottingham University Hospitals NHS Trust, Nottingham, UK. Electronic address: steve.chan@nuh.nhs.uk.
Lancet Oncol ; 17(7): 1004-1018, 2016 Jul.
Article em En | MEDLINE | ID: mdl-27312051
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Ciclo Celular / Proteoma / Genômica Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Ciclo Celular / Proteoma / Genômica Idioma: En Ano de publicação: 2016 Tipo de documento: Article